SuperGen Pulls U.S. Cancer Drug Application  NEW YORK (Reuters) - SuperGen Inc. on Monday said it has  withdrawn an application to market its pancreatic cancer  treatment in the United States due to insufficient data,  sending its shares down 17 percent. 

Which section of a newspaper would this article likely appear in? 